The High Cost Drugs Subgroups (HCDSG) were previously responsible for the development and update of pathways and commissioning statements relating to specified high cost drugs (i.e., PbR-excluded drugs). At certain points these functions were split between the High Cost Drugs Operational Group (HCDOG) and High Cost Drugs Strategic Group (HCDStG).

Minutes from meetings of these groups are available below.

Document Title Issue Date Review Date Status
HCDSG minutes August 2020 20200913 Sep 2020 Approved
HCDSG minutes June 2020 20200813 Aug 2020 Approved
HCDSG minutes February 2020 20200813 Aug 2020 Approved
HCD Strategic Group minutes November 2019 20200213 Feb 2020 Approved
HCD Operational Group minutes November 2019 20200213 Feb 2020 Approved
HCD Operational Group minutes October 2019 20191113 Nov 2019 Approved
HCD Strategic Group minutes September 2019 20191113 Nov 2019 Approved
HCD Operational Group minutes September 2019 20191013 Oct 2019 Approved
HCD Operational Group minutes August 2019 20190913 Sep 2019 Approved
HCD Operational Group minutes July 2019 20190813 Aug 2019 Approved
HCDSG minutes June 2019 20190713 Jul 2019 Approved
HCDSG minutes April 2019 20190613 Jun 2019 Approved
HCDSG minutes March 2019 20190413 Apr 2019 Approved
HCDSG minutes February 2019 20190313 Mar 2019 Approved
HCDSG minutes October 2018 20190213 Feb 2019 Approved
HCDSG minutes September 2018 20181013 Oct 2018 Approved
HCDSG minutes August 2018 20180913 Sep 2018 Approved
HCDSG minutes June 2018 20180813 Aug 2018 Approved
HCDSG minutes May 2018 20210613 Jun 2021 Approved
HCDSG minutes April 2018 20180513 May 2018 Approved
HCDSG minutes March 2018 20180413 Apr 2018 Approved
HCDSG minutes January 2018 20180313 Mar 2018 Approved